Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2014-02-18

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1073/pnas.1312245111PMID 24550511PMCID PMC3948312
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis.

  2013cited by this paper
• Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds

  2013cited by this paper
• Extracellular wildtype and mutant SOD1 induces ER–Golgi pathology characteristic of amyotrophic lateral sclerosis in neuronal cells

  2013cited by this paper
• The changing scene of amyotrophic lateral sclerosis

  2013cited by this paper
• Intracellular seeded aggregation of mutant Cu,Zn‐superoxide dismutase associated with amyotrophic lateral sclerosis

  2013cited by this paper
• Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype

  2013cited by this paper
• A Unifying Role for Prions in Neurodegenerative Diseases

  2012cited by this paper
• Aberrant Localization of FUS and TDP43 Is Associated with Misfolding of SOD1 in Amyotrophic Lateral Sclerosis

  2012influential reference
• Exosomes: Vehicles for the Transfer of Toxic Proteins Associated with Neurodegenerative Diseases?

  2012cited by this paper
• A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

  2011cited by this paper
• Clinical diagnosis and management of amyotrophic lateral sclerosis

  2011influential reference
• Generalization of the Prion Hypothesis to Other Neurodegenerative Diseases: An Imperfect Fit

  2011cited by this paper
• Intermolecular transmission of superoxide dismutase 1 misfolding in living cells

  2011influential reference
• Leading Edge Perspective The Seeds of Neurodegeneration : Prion-like Spreading in ALS

  2011cited by this paper
• Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

  2011cited by this paper
• Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis

  2011cited by this paper
• Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells

  2011influential reference
• Novel Antibodies Reveal Inclusions Containing Non-Native SOD1 in Sporadic ALS Patients

  2010cited by this paper
• Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS

  2010cited by this paper
• Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS

  2010cited by this paper
• Prion-like transmission of protein aggregates in neurodegenerative diseases

  2010cited by this paper
• Superoxide Dismutase 1 and tgSOD1G93A Mouse Spinal Cord Seed Fibrils, Suggesting a Propagative Cell Death Mechanism in Amyotrophic Lateral Sclerosis

  2010cited by this paper
• Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS

  2010influential reference
• Membrane vesicles as conveyors of immune responses

  2009cited by this paper
• ALS motor phenotype heterogeneity, focality, and spread

  2009cited by this paper
• Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria

  2008cited by this paper
• Establishment of a cell model of ALS disease: Golgi apparatus disruption occurs independently from apoptosis

  2008cited by this paper
• The role of exosomes in the processing of proteins associated with neurodegenerative diseases

  2008cited by this paper
• Sports and trauma in amyotrophic lateral sclerosis revisited.

  2007influential reference
• An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS

  2007cited by this paper
• Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis.

  2007cited by this paper
• Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice.

  2006cited by this paper
• Heparan Sulfate Is a Cellular Receptor for Purified Infectious Prions*

  2005cited by this paper
• Structural properties and neuronal toxicity of amyotrophic lateral sclerosis–associated Cu/Zn superoxide dismutase 1 aggregates

  2005cited by this paper
• Impaired Extracellular Secretion of Mutant Superoxide Dismutase 1 Associates with Neurotoxicity in Familial Amyotrophic Lateral Sclerosis

  2005cited by this paper
• Neuroblastoma × spinal cord (NSC) hybrid cell lines resemble developing motor neurons

  1992cited by this paper

• Fast and slow strains of misfolded mutant superoxide dismutase 1 in familial amyotrophic lateral sclerosis.

  2026cites this paper
• Decanoic Acid Treatment Alleviates Non-cell Autonomous Transfer of HD Pathology by Secretome of Mutant Huntingtin Expressing Cells

  2026cites this paper
• The interplay between autophagy and unconventional secretion in neurodegeneration.

  2026cites this paper
• Efficient induction of motor neuron disease in transgenic G93A SOD1 mice by prion-like seeding.

  2026cites this paper
• N‐Truncated Superoxide Dismutase‐1 in Cerebrospinal Fluid Is Folded and Active

  2026cites this paper
• Impaired nucleocytoplasmic transport in SOD1-mediated ALS

  2026cites this paper
• Novel extracellular vesicle release pathway facilitated by toxic superoxide dismutase 1 oligomers.

  2026cites this paper
• Heteroaggregation of Wild-Type and ALS Mutant SOD1.

  2025cites this paper
• Novel extracellular vesicle release pathway facilitated by toxic superoxide dismutase 1 oligomers

  2025cites this paper
• Theoretical evaluation of a bulky ortho-thioalkyl-azobenzene as an alternative to photocontrol structural cytotoxic effects of metal-free and disulfide oxidized hSOD1 in pathogenesis of ALS

  2025cites this paper
• Intercellular communication via exosomes: A new paradigm in the pathophysiology of neurodegenerative disorders.

  2025cites this paper
• Exploring Protein Misfolding in Amyotrophic Lateral Sclerosis: Structural and Functional Insights

  2025cites this paper
• Cutting-edge treatments in amyotrophic lateral sclerosis: the role of molecular pathogenesis in targeted therapies

  2025cites this paper
• From Yeast to Therapeutics: Modeling Neurodegenerative Diseases in Saccharomyces cerevisiae

  2025cites this paper
• Development of a targeted BioPROTAC degrader selective for misfolded SOD1

  2025cites this paper
• Regulatory Roles of Exosomes in Aging and Aging-Related Diseases

  2025cites this paper
• Metabolic Reprogramming in Primary Microglial Cell and Extracellular Vesicle Triggered by Aβ Exposure

  2025cites this paper
• Trimeric superoxide dismutase 1 antibody as a universal biomarker for ALS

  2025influential citation
• New perspectives on the glymphatic system and the relationship between glymphatic system and neurodegenerative diseases.

  2025cites this paper
• Modifications of NU-9, a potent protein aggregation inhibitor. Properties and activity in a cellular model of amyotrophic lateral sclerosis

  2025cites this paper
• The potential role of misfolded wild-type SOD1 protein in sporadic amyotrophic lateral sclerosis (ALS): a review of the evidence.

  2025cites this paper
• Non-invasive MRI measurements of age-dependent in vivo human glymphatic exchange using magnetization transfer spin labeling

  2025cites this paper
• Small HSPs at the crossroad between protein aggregation, autophagy and unconventional secretion: clinical implications and potential therapeutic opportunities in the context of neurodegenerative diseases

  2025cites this paper
• Impact of SOD1 Transcript Variants on Amyotrophic Lateral Sclerosis Severity

  2025cites this paper
• SOD1 Protein Content in Human Central Nervous System and Peripheral Tissues

  2025cites this paper
• The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration

  2025cites this paper
• Astrocyte-Neuron Interactions Contributing to Amyotrophic Lateral Sclerosis Progression.

  2024cites this paper
• Plekhg5 controls the unconventional secretion of Sod1 by presynaptic secretory autophagy

  2024cites this paper
• Autophagy and exosomes; inter-connected maestros in Alzheimer’s disease

  2024cites this paper
• Mass spectrometry imaging of SOD1 protein-metal complexes in SOD1G93A transgenic mice implicates demetalation with pathology

  2024cites this paper
• Research progress on astrocyte-derived extracellular vesicles in the pathogenesis and treatment of neurodegenerative diseases

  2024cites this paper
• The Neuromuscular Disorder Mediated by Extracellular Vesicles in Amyotrophic Lateral Sclerosis

  2024cites this paper
• Seeding activity of human superoxide dismutase 1 aggregates in familial and sporadic amyotrophic lateral sclerosis postmortem neural tissues by real-time quaking-induced conversion

  2024cites this paper
• Targeting low levels of MIF expression as a potential therapeutic strategy for ALS

  2024cites this paper
• Updates on Disease Mechanisms and Therapeutics for Amyotrophic Lateral Sclerosis

  2024cites this paper
• CNS cell-derived exosome signatures as blood-based biomarkers of neurodegenerative diseases

  2024cites this paper
• High-content analysis of proteostasis capacity in cellular models of amyotrophic lateral sclerosis (ALS)

  2024cites this paper
• Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers

  2024cites this paper
• Molecular hallmarks of ageing in amyotrophic lateral sclerosis

  2024cites this paper
• BI1 Activates Autophagy and Mediates TDP43 to Regulate ALS Pathogenesis

  2024cites this paper
• Oxidized SOD1 accelerates cellular senescence in neural stem cells

  2024cites this paper
• Exosome Cargo in Neurodegenerative Diseases: Leveraging Their Intercellular Communication Capabilities for Biomarker Discovery and Therapeutic Delivery

  2024cites this paper
• The Role of Extracellular Vesicles and Microparticles in Central Nervous System Disorders: Mechanisms, Biomarkers, and Therapeutic Potential

  2024cites this paper
• Current potential pathogenic mechanisms of copper-zinc superoxide dismutase 1 (SOD1) in amyotrophic lateral sclerosis

  2024cites this paper
• Neuropathogenesis-on-chips for neurodegenerative diseases

  2024cites this paper
• Inflammatory cytokines disrupt astrocyte exosomal HepaCAM-mediated protection against neuronal excitotoxicity in the SOD1G93A ALS model

  2024cites this paper
• Inferring gene regulatory networks of ALS from blood transcriptome profiles

  2024cites this paper
• Nitric Oxide/Nitric Oxide Synthase System in the Pathogenesis of Neurodegenerative Disorders—An Overview

  2023cites this paper
• Attenuation of amyotrophic lateral sclerosis via stem cell and extracellular vesicle therapy: An updated review

  2023cites this paper
• Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis

  2023cites this paper
• The role of exosomes in adult neurogenesis: implications for neurodegenerative diseases

  2023cites this paper
• Coordination chemistry of mitochondrial copper metalloenzymes: exploring implications for copper dyshomeostasis in cell death

  2023cites this paper
• Intracellular spatially-targeted chemical chaperones increase native state stability of mutant SOD1 barrel

  2023cites this paper
• Multiple Factors Influence the Incubation Period of ALS Prion-like Transmission in SOD1 Transgenic Mice

  2023cites this paper
• Cilia and Extracellular Vesicles in Brain Development and Disease.

  2023cites this paper
• Amyloidogenic regions in beta-strands II and III modulate the aggregation and toxicity of SOD1 in living cells

  2023cites this paper
• Employing nanoparticle tracking analysis of salivary neuronal exosomes for early detection of neurodegenerative diseases

  2023cites this paper
• Intercellular transmission of pathogenic proteins in ALS: Exploring the pathogenic wave.

  2023cites this paper
• Structure-based discovery of an antipsychotic drug, paliperidone, as a modulator of human superoxide dismutase 1: a potential therapeutic target in amyotrophic lateral sclerosis.

  2023cites this paper
• Blocking an epitope of misfolded SOD1 ameliorates disease phenotype in a model of amyotrophic lateral sclerosis.

  2023cites this paper
• The Roles of Exosomal Proteins: Classification, Function, and Applications

  2023cites this paper
• Potential roles of the endoplasmic reticulum stress pathway in amyotrophic lateral sclerosis

  2023cites this paper
• Looking to the Future of the Role of Macrophages and Extracellular Vesicles in Neuroinflammation in ALS

  2023cites this paper
• Recent Advances in Extracellular Vesicles in Amyotrophic Lateral Sclerosis and Emergent Perspectives

  2023cites this paper
• Acute Kidney Injury by Ischemia/Reperfusion and Extracellular Vesicles

  2023cites this paper
• Cryo-EM structure of an amyloid fibril formed by full-length human SOD1 reveals its conformational conversion

  2022cites this paper
• Progress in biophysics and molecular biology proteostasis impairment and ALS.

  2022cites this paper
• Unfolding and aggregation of oxidized metal-deficient superoxide dismutase and isoflavone inhibition based on ion mobility mass spectrometry and ThT fluorescence assay.

  2022cites this paper
• Prionoids in amyotrophic lateral sclerosis

  2022cites this paper
• Accumulation of misfolded SOD1 outlines distinct patterns of motor neuron pathology and death during disease progression in a SOD1G93A mouse model of amyotrophic lateral sclerosis

  2022cites this paper
• Prions as Non-Canonical Hereditary Factors

  2022cites this paper
• Cell Non-autonomous Proteostasis Regulation in Aging and Disease

  2022cites this paper
• Research progress on vesicular trafficking in amyotrophic lateral sclerosis.

  2022cites this paper
• Pathogenic Extracellular Vesicle (EV) Signaling in Amyotrophic Lateral Sclerosis (ALS)

  2022cites this paper
• P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons

  2022cites this paper
• Challenges in the Development of Drug Delivery Systems Based on Small Extracellular Vesicles for Therapy of Brain Diseases

  2022cites this paper
• The Neurotoxicity of Vesicles Secreted by ALS Patient Myotubes Is Specific to Exosome-Like and Not Larger Subtypes

  2022cites this paper
• Neurodegenerative Disease-Associated TDP-43 Fragments Are Extracellularly Secreted with CASA Complex Proteins

  2022cites this paper
• Stem Cells From Human Exfoliated Deciduous Teeth-Conditioned Medium (SHED-CM) is a Promising Treatment for Amyotrophic Lateral Sclerosis

  2022cites this paper
• Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases.

  2022cites this paper
• Tetrabutylammonium based ionic liquids (ILs) inhibit the amyloid aggregation of superoxide dismutase 1 (SOD1)

  2022cites this paper
• Cysteine String Protein Controls Two Routes of Export for Misfolded Huntingtin

  2022cites this paper
• Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids

  2022cites this paper
• The amyloid state of proteins: A boon or bane?

  2022cites this paper
• Extracellular Vesicles in Amyotrophic Lateral Sclerosis

  2022cites this paper
• Extracellular chaperone networks and the export of J-domain proteins

  2022cites this paper
• Characterization of a case of chromosome 21 SOD1 mutation in a patient with familial amyotrophic lateral sclerosis: Discussion on the topic

  2022cites this paper
• 4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS Mice

  2022cites this paper
• SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells

  2022cites this paper
• Recent Advances in the Application of Mesenchymal Stem Cell-Derived Exosomes for Cardiovascular and Neurodegenerative Disease Therapies

  2022cites this paper
• Misfolding at the synapse: A role in amyotrophic lateral sclerosis pathogenesis?

  2022cites this paper
• Extracellular vesicles: A new paradigm in understanding, diagnosing and treating neurodegenerative disease

  2022cites this paper
• Hunting for the cause: Evidence for prion-like mechanisms in Huntington’s disease

  2022influential citation
• Extracellular Vesicles and Acute Kidney Injury: Potential Therapeutic Avenue for Renal Repair and Regeneration

  2022cites this paper
• Huntingtin Co-Isolates with Small Extracellular Vesicles from Blood Plasma of TgHD and KI-HD Pig Models of Huntington’s Disease and Human Blood Plasma

  2022cites this paper
• Molecular dynamics analysis of superoxide dismutase 1 mutations suggests decoupling between mechanisms underlying ALS onset and progression

  2022cites this paper
• SOD1 gains pro-oxidant activity upon aberrant oligomerization: change in enzymatic activity by intramolecular disulfide bond cleavage

  2022cites this paper
• Exosomes as Smart Nanoplatforms for Diagnosis and Therapy of Cancer

  2021cites this paper
• Phosphorylated TAR DNA-Binding Protein-43: Aggregation and Antibody-Based Inhibition.

  2021cites this paper
• Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration

  2021cites this paper